All Stories

  1. Problematic Online Gaming and Gambling Among First-Year University Students: Identification of Profiles and Psychological Vulnerabilities
  2. World Federation of Societies of Biological Psychiatry (WFSBP) consensus statement on candidate biomarkers for anorexia nervosa
  3. Validity and Reliability of Tools to Measure Ultra-Processed Food Intake under the NOVA System: A Systematic Review
  4. Food addiction in behavioral addictions: a network approach
  5. Three-year effects of a multidomain lifestyle intervention on impulsivity: Results from a randomized clinical trial
  6. Eating Disorders in an Immigrant Population: Are Clinical Features and Treatment Outcomes Different from the Native-Born Spanish Population?
  7. Mapping the genetic landscape across 14 psychiatric disorders
  8. Neurocognitive impairments in eating disorders patients with and without comorbid food addiction
  9. Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity
  10. Detection of Self-Induced Vomiting in Eating Disorders Through Oral Microbiota Profiling
  11. Changes in Difficulties in Emotion Regulation Following Eating Disorders Treatment: Relevant Prospective Implications for Treatment Outcome
  12. Longitudinal dynamics of impulsivity in individuals undergoing obesity surgery – a systematic review
  13. Salivary Characteristics and Other Risk Factors Associated with the Severity of Chemical and Mechanical Tooth Wear in At-Risk Groups: A Cross-Sectional Study
  14. Addressing Heterogeneity in Binge Eating Disorder: A Cluster Analysis Approach Based on Age of Onset, Clinical and Psychopathological Features
  15. A Longitudinal Examination of the Mediating Role of Body Dissatisfaction in the Relationship Between Pornography Use Frequency and Eating Disturbances: A Cross-Lagged Mediation Model
  16. Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
  17. Leveraging transdiagnostic genetic liability to psychiatric disorders to dissect clinical outcomes of anorexia nervosa
  18. Validation of the Problematic Pornography Consumption Scale: Short Form (PPCS-6) in a Spanish Clinical Population with Gambling Disorder
  19. Impact of Preoperative Food Addiction on Weight Loss and Weight Regain Three Years After Bariatric Surgery
  20. Emotional dysregulation, obsessive-compulsive traits, and eating disorders: three constructs for one spectrum?
  21. Correction: Sex differences in problematic pornography use among adolescents: a network analysis
  22. Dietary vitamin D intake and 2-year changes in cognitive function in older adults with overweight or obesity and metabolic syndrome
  23. Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions
  24. Sex differences in problematic pornography use among adolescents: a network analysis
  25. Exploring Food Addiction Across Several Behavioral Addictions: Analysis of Clinical Relevance
  26. Gambling disorder and problematic pornography use: Does co-occurrence influence treatment outcome?
  27. The impact of gambling advertising on gambling severity: a path analysis of factors of psychological distress in individuals with gambling disorder
  28. Kleptomania on the impulsive–compulsive spectrum. Clinical and therapeutic considerations for women
  29. Athletes with eating disorders: clinical-psychopathological features and gender differences
  30. Genome-wide association studies of binge eating behaviour and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes
  31. The current clinical approach to feeding and eating disorders aimed to increase personalization of management
  32. Features related to the presence of internet gaming disorder and their impact on the treatment outcomes
  33. Maladaptive eating behaviors and health-related quality of life in Spanish children
  34. Unveiling Severity Indicators for Anorexia and Bulimia Nervosa Treatment Success: DSM–5 Versus ICD–11 Versus Drive for Thinness
  35. HyperChildNET COST Action CA19115: report of the task force
  36. Eating disorder debut cases during COVID‐19 lockdown in adults. Exploring differences in treatment outcome contrasting with pre‐pandemic onset cases
  37. Pornography Use and Associated Factors in Adolescents: A Cross-Jurisdictional Approach (Spain vs. Mexico)
  38. The prognostic role of food addiction for weight loss treatment outcomes in individuals with overweight and obesity: A systematic review and meta‐analysis
  39. Treatment Targets and Strategies for Eating Disorders Recovery: A Delphi Consensus With Lived Experience, Carers, Researchers, and Clinicians
  40. Emotion Regulation, Eating Psychopathology, and Putative Transdiagnostic Psychological Processes: Findings from an Exploratory Network Analysis in a College Sample
  41. Rethinking cutoff values for the South Oaks Gambling Screen: Sex-specific insights and DSM-5 severity adjustments in Gambling Disorder assessment
  42. Spanish Validation of the Brief Pornography Screen Within a Clinical Sample of Individuals with Gambling Disorder
  43. Online Gaming Disorder and Sports Betting Addiction: Convergences and Divergences
  44. Getting even: chasing behavior, decision-making, and craving in habitual gamblers
  45. Glycated hemoglobin, type 2 diabetes, and poor diabetes control are positively associated with impulsivity changes in aged individuals with overweight or obesity and metabolic syndrome
  46. Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial
  47. Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial
  48. Suicide in patients with eating disorders: lessons to learn
  49. Perceived Impact of Gambling Advertising can Predict Gambling Severity among Patients with Gambling Disorder
  50. Defining and Assessing International Classification of Disease Suicidality Phenotypes for Genetic Studies
  51. The Impact of High Levels of Compensatory Exercise on Treatment Outcomes in Threshold and Subthreshold Bulimia Nervosa
  52. A path analysis model of the effects of gambling advertising on people diagnosed with gambling disorder
  53. Statistical predictors of the co-occurrence between gambling disorder and problematic pornography use
  54. Self-compassion, difficulties in emotion regulation and eating psychopathology: Findings from an eating disorders clinical sample and a college sample
  55. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention
  56. Shared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis
  57. Shared familial risk for type 2 diabetes mellitus and psychiatric disorders: a nationwide multigenerational genetics study
  58. Network analysis of DSM-5 criteria for gambling disorder: considering sex differences in a large clinical sample
  59. The association of glucose metabolism measures and diabetes status with Alzheimer’s disease biomarkers of amyloid and tau: A systematic review and meta-analysis
  60. Eating disorders and obesity: bridging clinical, neurobiological, and therapeutic perspectives
  61. Science around the world
  62. Local patterns of genetic sharing challenge the boundaries between neuropsychiatric and insulin resistance-related conditions
  63. Association between endocrine and neuropsychological endophenotypes and gambling disorder severity
  64. Probiotic and prebiotic interventions in eating disorders: A narrative review
  65. Connecting genomic results for psychiatric disorders to human brain cell types and regions reveals convergence with functional connectivity
  66. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population
  67. Do risk factors differentiate DSM-5 and drive for thinness severity groups for anorexia nervosa?
  68. Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis
  69. Do attention-deficit/hyperactivity symptoms influence treatment outcome in gambling disorder?
  70. COVID-19 and Cognitive Decline in Older Adults with High-Cardiovascular Risk: A Post Hoc Analysis
  71. Complicaciones médicas en anorexia y bulimia nerviosa
  72. Quantifying the economic value of earlier and enhanced management of anorexia nervosa for adults in England, Germany and Spain: improving the care pathway
  73. Understanding the Co-occurrence of Gambling Disorder and Problematic Pornography Use: Exploring Sociodemographic and Clinical Factors
  74. Microbial Phenolic Metabolites Are Associated with Improved Cognitive Health
  75. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial
  76. A Network Approach of Gambling Disorder Profile with and Without Related Illegal Acts
  77. Psychosocial and environmental risk factors of obesity and hypertension in children and adolescents—a literature overview
  78. Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlates in gambling disorder
  79. Differences in gambling disorder recovery capital toolkits in mothers versus childless women.
  80. A nationwide case–control study on cardiovascular and respiratory-related disorders in patients with gambling disorder in Sweden
  81. Plasma concentration of leptin is related to food addiction in gambling disorder: Clinical and neuropsychological implications
  82. Spanish Validation of the Long and Short Versions of the Problematic Pornography Consumption Scale (PPCS and PPCS-6) in Adolescents
  83. Editorial: Neurological, psychological and endocrine markers of eating disorders and obesity
  84. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort
  85. Social, clinical, and policy implications of ultra-processed food addiction
  86. How to assess eating disorder severity in males?The DSM-5 severity index versus severity based on drive for thinness
  87. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors
  88. Actualización sobre los aspectos neurobiológicos, clínicos y de tratamiento sobre el juego patológico
  89. Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity
  90. The Relationship between Depressive Symptoms, Quality of Life and miRNAs 8 Years after Bariatric Surgery
  91. Food Addiction and Impulsivity in Clinical Populations by Gender: a Systematic Review
  92. Cognitive flexibility and DSM-5 severity criteria for eating disorders: assessing drive for thinness and duration of illness as alternative severity variables
  93. Sex differences in problematic pornography use among adolescents: a network analysis
  94. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome
  95. Eating Disorders and Addictive Behaviors: Implications for Human Health
  96. Exploring the relationship between emotion regulation, inhibitory control, and eating psychopathology in a non‐clinical sample
  97. Dynamic fronto‐amygdalar interactions underlying emotion‐regulation deficits in women at higher weight
  98. Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study
  99. How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?
  100. Mind the gap ‐ A brief echo and some contributions from eating disorder experts from other European countries
  101. Biofeedback Interventions for Impulsivity-related Processes in Addictive Disorders
  102. Insulin and disorders of behavioural flexibility
  103. Athletes with Eating Disorders: Analysis of Their Clinical Characteristics, Psychopathology and Response to Treatment
  104. Attitudes, Behaviors, and Barriers among Adolescents Living with Obesity, Caregivers, and Healthcare Professionals in Spain: ACTION Teens Survey Study
  105. Are there clinical, psychopathological and therapy outcomes correlates associated with self-exclusion from gambling?
  106. The usefulness of an intervention with a serious video game as a complementary approach to cognitive behavioural therapy in eating disorders: A pilot randomized clinical trial for impulsivity management
  107. The Role of Food Addiction and Lifetime Substance Use on Eating Disorder Treatment Outcomes
  108. Development of gambling disorder after bariatric surgery: a call for research
  109. Exploring the Influence of Circulating Endocannabinoids and Nucleus Accumbens Functional Connectivity on Anorexia Nervosa Severity
  110. Applying psycho-behavioural phenotyping in obesity characterization
  111. COVID-19, Health Habits, and Addictive Behaviors in the General Population
  112. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders
  113. Food addiction and its relationship with other eating behaviours among Spanish university students
  114. Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 2. How to manage high blood pressure in children and adolescents
  115. Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents
  116. HyperChildNET: A European Network Moving Forward in the Field of Pediatric Hypertension
  117. Neuroendocrinological factors in binge eating disorder: A narrative review
  118. Obsessive-compulsive, harm-avoidance and persistence tendencies in patients with gambling, gaming, compulsive sexual behavior and compulsive buying-shopping disorders/concerns
  119. Eating disorders during lockdown: the transcultural influence on eating and mood disturbances in Ibero-Brazilian population
  120. Independent component analysis for internet gaming disorder
  121. The Predictive Role of Tolerance and Health Problems in Problem Gambling: A Cross-Sectional and Cross-Lagged Network Analyses
  122. Gambling disorder duration and cognitive behavioural therapy outcome considering gambling preference and sex
  123. Editorial: Blood pressure in children and adolescents: Moving forward
  124. Underlying Mechanisms Involved in Gambling Disorder Severity: A Pathway Analysis Considering Genetic, Psychosocial, and Clinical Variables
  125. The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey
  126. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
  127. Impulsivity and compulsivity in gambling disorder and bulimic spectrum eating disorders: Analysis of neuropsychological profiles and sex differences
  128. Pathways to eating disorder care: A European multicenter study
  129. Common and differential risk factors behind suicidal behavior in patients with impulsivity-related disorders: The case of bulimic spectrum eating disorders and gambling disorder
  130. Network Analysis of the Structure of the Core Symptoms and Clinical Correlates in Comorbid Schizophrenia and Gambling Disorder
  131. Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans
  132. Cognitive and clinical gender‐related differences among binge‐spectrum eating disorders: Analysis of therapy response predictors
  133. DSM–5 severity ratings for eating disorders: Some clinical implications and future directions.
  134. Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome
  135. The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review
  136. Are Signals Regulating Energy Homeostasis Related to Neuropsychological and Clinical Features of Gambling Disorder? A Case–Control Study
  137. Impact of Impulsivity and Therapy Response in Eating Disorders from a Neurophysiological, Personality and Cognitive Perspective
  138. Roles for Alexithymia, Emotion Dysregulation and Personality Features in Gambling Disorder: A Network Analysis
  139. Correction: Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial
  140. e-Estesia: A Serious Game for Reducing Arousal, Improving Emotional Regulation and Increasing Wellbeing in Individuals with Gambling Disorder
  141. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses
  142. Prevalence of left ventricular hypertrophy in children and young people with primary hypertension: Meta-analysis and meta-regression
  143. Food addiction in Bulimia Nervosa: Analysis of body composition, psychological and problematic foods profile
  144. Knowledge gaps and future directions in cognitive functions in children and adolescents with primary arterial hypertension: A systematic review
  145. Cyberbullying and Gambling Disorder: Associations with Emotion Regulation and Coping Strategies
  146. Sports-betting-related gambling disorder: Clinical features and correlates of cognitive behavioral therapy outcomes
  147. Common Genetic Variation and Age of Onset of Anorexia Nervosa
  148. Cognitive Behavioral Therapy Plus a Serious Game as a Complementary Tool for a Patient With Parkinson Disease and Impulse Control Disorder: Case Report
  149. Research in eating disorders: the misunderstanding of supposing serious mental illnesses as a niche specialty
  150. Temporally ordered associations between type 2 diabetes and brain disorders – a Danish register-based cohort study
  151. Exploring the Association between Gambling-Related Offenses, Substance Use, Psychiatric Comorbidities, and Treatment Outcome
  152. Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial
  153. Understanding exercise addiction, psychiatric characteristics and use of anabolic androgenic steroids among recreational athletes – An online survey study
  154. Dietary diversity and depression: cross-sectional and longitudinal analyses in Spanish adult population with metabolic syndrome. Findings from PREDIMED-Plus trial
  155. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study
  156. Latent Classes for the Treatment Outcomes in Women with Gambling Disorder and Buying/Shopping Disorder
  157. Genome-wide association study meta-analysis of suicide attempt identifies twelve genome-wide significant loci and implicates genetic risks for specific health factors
  158. Exploring Internet gaming disorder: an updated perspective of empirical evidence (from 2016 to 2021)
  159. Impact of Food Addiction in Therapy Response in Obesity and Eating Disorders
  160. Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions
  161. Motherhood and Treatment Outcome in Female Patients with Compulsive Buying–Shopping Disorder
  162. The mediating role of self‐criticism, experiential avoidance and negative urgency on the relationship between ED‐related symptoms and difficulties in emotion regulation
  163. The role of neurotrophin genes involved in the vulnerability to gambling disorder
  164. Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study
  165. The Relationship of Shopping-Related Decisions with Materialistic Values Endorsement, Compulsive Buying-Shopping Disorder Symptoms and Everyday Moral Decision Making
  166. Emotion regulation as a transdiagnostic factor in eating disorders and gambling disorder: Treatment outcome implications
  167. Food addiction and lifetime alcohol and illicit drugs use in specific eating disorders
  168. Phenotype of Gambling Disorder Patients with Lotteries as a Preferred Form of Gambling
  169. Age and Gender Considerations with Respect to Gambling-Disorder Severity and Impulsivity and Self-control
  170. Food addiction in anorexia nervosa: Implications for the understanding of crossover diagnosis
  171. Binge eating disorder
  172. Delay Discounting in Gambling Disorder: Implications in Treatment Outcome
  173. Food Addiction in Eating Disorders: A Cluster Analysis Approach and Treatment Outcome
  174. COVID-19 and Behavioral Addictions: Worrying consequences?
  175. Do emotion regulation and impulsivity differ according to gambling preferences in clinical samples of gamblers?
  176. Adicción al juego: ¿mito o realidad? Evidencias científicas sobre el trastorno de juego
  177. Vitamin K dietary intake is associated with cognitive function in an older adult Mediterranean population
  178. Exploring the pathways model in a sample of patients with gambling disorder
  179. Bridging of childhood obsessive‐compulsive personality disorder traits and adult eating disorder symptoms: A network analysis approach
  180. Half of the patients with subepithelial tumours present borderline or pathologic anxiety-distress and carcinophobia: multicentre cohort study
  181. Factors related to the dual condition of gambling and gaming disorders: A path analysis model
  182. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
  183. Clustering Treatment Outcomes in Women with Gambling Disorder
  184. Does Confinement Affect Treatment Dropout Rates in Patients With Gambling Disorder? A Nine-Month Observational Study
  185. Transdiagnostic Perspective of Impulsivity and Compulsivity in Obesity: From Cognitive Profile to Self-Reported Dimensions in Clinical Samples with and without Diabetes
  186. Discrete Roles for Impulsivity and Compulsivity in Gambling Disorder
  187. Subtyping treatment-seeking gaming disorder patients
  188. Women and gambling disorder: Assessing dropouts and relapses in cognitive behavioral group therapy
  189. Clinical factors predicting impaired executive functions in eating disorders: The role of illness duration
  190. A proof-of-concept study applying machine learning methods to putative risk factors for eating disorders: results from the multi-centre European project on healthy eating
  191. Where does purging disorder lie on the symptomatologic and personality continuum when compared to other eating disorder subtypes? Implications for the DSM
  192. Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain
  193. Suicidal behavior in patients with gambling disorder and their response to psychological treatment: The roles of gender and gambling preference
  194. Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study
  195. Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study
  196. Prevalence of Suicidal Behavior and Associated Clinical Correlates in Patients with Behavioral Addictions
  197. New challenges in the field of eating disorders
  198. Identifying Associated Factors for Illegal Acts among Patients with Gambling Disorder and ADHD
  199. Profile of Treatment-Seeking Gaming Disorder Patients: A Network Perspective
  200. Eating disorder in gambling disorder: A group with increased psychopathology
  201. The neural correlates of delay discounting in obesity and binge eating disorder
  202. Emotional regulation in eating disorders and gambling disorder: A transdiagnostic approach
  203. Psychopathogical status and personality correlates of problem gambling severity in sports bettors undergoing treatment for gambling disorder
  204. Metformin Use and Cognitive Function in Older Adults With Type 2 Diabetes Following a Mediterranean Diet Intervention
  205. Association between ankle-brachial index and cognitive function in participants in the PREDIMED-Plus study: cross-sectional assessment
  206. Asociación entre índice tobillo-brazo y rendimiento cognitivo en participantes del estudio PREDIMED-Plus: estudio transversal
  207. Clinical Features of Gambling Disorder Patients with and Without Food Addiction: Gender-Related Considerations
  208. Tracking temporal response dynamics in the ventral striatum during social feedback in anorexia nervosa: A functional magnetic resonance imaging exploratory study
  209. Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders and known risk factors
  210. Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial
  211. Metabolic, Affective and Neurocognitive Characterization of Metabolic Syndrome Patients with and without Food Addiction. Implications for Weight Progression
  212. Longitudinal Associations Between Glycemic Status and Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-Up in the PREDIMED-Plus Study
  213. Executive functions in binge spectrum eating disorders with comorbid compulsive buying
  214. Gambling-Like Day Trading During the COVID-19 Pandemic – Need for Research on a Pandemic-Related Risk of Indebtedness and Mental Health Impact
  215. Neuropsychological Learning Deficits as Predictors of Treatment Outcome in Patients with Eating Disorders
  216. Risk patterns in food addiction: a Mexican population approach
  217. Lifetime Weight Course as a Phenotypic Marker of Severity and Therapeutic Response in Patients with Eating Disorders
  218. The factorial structure and psychometric properties of the Committed Action Questionnaire (CAQ‐8) in a Portuguese clinical sample with eating disorders
  219. European Network for blood pressure research in children and adolescents (COST Action CA 19115)
  220. Red europea para la investigación de la presión arterial en niños y adolescentes (COST Action CA19115)
  221. The transition time to gambling disorder: The roles that age, gambling preference and personality traits play
  222. Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome
  223. Psychological and metabolic risk factors in older adults with a previous history of eating disorder: A cross‐sectional study from the Predimed‐Plus study
  224. The prevalence and features of schizophrenia among individuals with gambling disorder
  225. Gambling activity in the old-age general population
  226. Longitudinal Changes in Gambling, Buying and Materialism in Adolescents: A Population-Based Study
  227. Milk and Dairy Products Intake Is Related to Cognitive Impairment at Baseline in Predimed Plus Trial
  228. A Serious Game to Improve Emotion Regulation in Treatment-Seeking Individuals With Gambling Disorder: A Usability Study
  229. Gambling disorder seeking treatment patients and tobacco use in relation to clinical profiles
  230. Optimising care pathways for adult anorexia nervosa. What is the evidence to guide the provision of high‐quality, cost‐effective services?
  231. The impact of duration of illness on treatment nonresponse and drop‐out: Exploring the relevance of enduring eating disorder concept
  232. Value of treatment for eating disorders
  233. AN-VR-BE. A Randomized Controlled Trial for Reducing Fear of Gaining Weight and Other Eating Disorder Symptoms in Anorexia Nervosa through Virtual Reality-Based Body Exposure
  234. Youth and gambling disorder: What about criminal behavior?
  235. Gender and gambling disorder: Differences in compulsivity-related neurocognitive domains
  236. Illness perception in patients with eating disorders: clinical, personality, and food addiction correlates
  237. Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders and known risk factors
  238. Contribution of stressful life events to gambling activity in older age
  239. Pornography Use in Adolescents and Its Clinical Implications
  240. Comorbid behavioral and substance-related addictions in young population with and without gambling disorder
  241. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population
  242. Contribution of sex on the underlying mechanism of the gambling disorder severity
  243. Validity of Virtual Reality Body Exposure to Elicit Fear of Gaining Weight, Body Anxiety and Body-Related Attentional Bias in Patients with Anorexia Nervosa
  244. Coronavirus disease 2019 ( COVID ‐19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease
  245. Drive for thinness provides an alternative, more meaningful, severity indicator than the DSM ‐5 severity indices for eating disorders
  246. COVID Isolation Eating Scale ( CIES ): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study
  247. A cluster analysis of purging disorder: Validation analyses with eating disorder symptoms, general psychopathology and personality
  248. Effectiveness and influencing factors of online education for caregivers of patients with eating disorders during COVID ‐19 pandemic in China
  249. COVID ‐19 and eating disorders during confinement: Analysis of factors associated with resilience and aggravation of symptoms
  250. Exploring the Predictive Value of Gambling Motives, Cognitive Distortions, and Materialism on Problem Gambling Severity in Adolescents and Young Adults
  251. Null hypothesis significance tests, a misleading approach to scientific knowledge: Some implications for eating disorders research
  252. A Comparison of Gambling-Related Cognitions and Behaviors in Gamblers from the United States and Spain
  253. WITHDRAWN: Emotional regulation in gambling disorder
  254. Dorsolateral prefrontal cortex and amygdala function during cognitive reappraisal predicts weight restoration and emotion regulation impairment in anorexia nervosa
  255. Does ADHD Symptomatology Influence Treatment Outcome and Dropout Risk in Eating Disorders? A longitudinal Study
  256. Buying-shopping disorder, emotion dysregulation, coping and materialism: a comparative approach with gambling patients and young people and adolescents
  257. Predicting Eating Disorder and Anxiety Symptoms Using Anorexia Nervosa and Obsessive-Compulsive Disorder Polygenic Scores
  258. Decision-Making in Gambling Disorder, Problematic Pornography Use, and Binge-Eating Disorder: Similarities and Differences
  259. State-Based Markers of Disordered Eating Symptom Severity
  260. Time to make a change: A call for more experimental research on key mechanisms in anorexia nervosa
  261. Impulsivity, Emotional Dysregulation and Executive Function Deficits Could Be Associated with Alcohol and Drug Abuse in Eating Disorders
  262. The influence of chronological age on cognitive biases and impulsivity levels in male patients with gambling disorder
  263. Gambling Phenotypes in Online Sports Betting
  264. The Severity of Gambling and Gambling Related Cognitions as Predictors of Emotional Regulation and Coping Strategies in Adolescents
  265. Presence of problematic and disordered gambling in older age and validation of the South Oaks Gambling Scale
  266. Gambling During the COVID-19 Crisis – A Cause for Concern
  267. COVID ‐19 and implications for eating disorders
  268. A review of binge eating disorder and obesity
  269. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease
  270. Response trajectories of gambling severity after cognitive behavioral therapy in young-adult pathological gamblers
  271. Explicit and Implicit Emotional Expression in Gambling Disorder Measured by a Serious Game: A Pilot Study
  272. Clinical and Neurophysiological Correlates of Emotion and Food Craving Regulation in Patients with Anorexia Nervosa
  273. Emotional and non‐emotional facets of impulsivity in eating disorders: From anorexia nervosa to bulimic spectrum disorders
  274. Clustering Gambling Disorder Patients with Lotteries as a Preferred Form of Gambling
  275. Moderator effect of sex in the clustering of treatment-seeking patients with gambling problems
  276. Problem Gambling in the Fitness World—A General Population Web Survey
  277. Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies
  278. Comparison of gambling profiles based on strategic versus non-strategic preferences
  279. Emotional regulation in gambling disorder
  280. The Potential Role of the Early Maladaptive Schema in Behavioral Addictions Among Late Adolescents and Young Adults
  281. Dimensions of Impulsivity in Gambling Disorder
  282. Does Money Control Enhance the Effectiveness of CBT for Gambling Disorder?
  283. The Role of ADHD Symptomatology and Emotion Dysregulation in Gambling Disorder
  284. Gambling Phenotypes in Older Adults
  285. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
  286. How Can Partners Influence the Gambling Habits of Their Gambler Spouse?
  287. Psychological predictors of poor weight loss following LSG: relevance of general psychopathology and impulsivity
  288. Food Addiction in Eating Disorders and Obesity: Analysis of Clusters and Implications for Treatment
  289. Homeostasis disrupted: Eating disorders as a paradigm of psychosomatic disorders
  290. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making
  291. Is food addiction a predictor of treatment outcome among patients with eating disorder?
  292. Psychometric properties of the Weight Locus of Control Scale (MWLCS): study with Spanish individuals of different anthropometric nutritional status
  293. Associations Between Attention-Deficit/Hyperactivity Disorder and Various Eating Disorders: A Swedish Nationwide Population Study Using Multiple Genetically Informative Approaches
  294. What Difference Does it Make? Risk-Taking Behavior in Obesity after a Loss is Associated with Decreased Ventromedial Prefrontal Cortex Activity
  295. Differences in Emotion Regulation Considering Gender, Age, and Gambling Preferences in a Sample of Gambling Disorder Patients
  296. Evidence and perspectives in eating disorders: a paradigm for a multidisciplinary approach
  297. Neuroendocrinological mechanisms underlying impulsive and compulsive behaviors in obesity: a narrative review of fMRI studies
  298. Impulsivity and cognitive distortions in different clinical phenotypes of gambling disorder: Profiles and longitudinal prediction of treatment outcomes
  299. Shared Genetic Risk between Eating Disorder- and Substance-Use-Related Phenotypes: Evidence from Genome-Wide Association Studies
  300. A multimodal MRI study of the neural mechanisms of emotion regulation impairment in women with obesity
  301. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study
  302. Developmental trajectories of gambling severity after cognitive-behavioral therapy
  303. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa
  304. Corrigendum: Phenotypes in Gambling Disorder Using Sociodemographic and Clinical Clustering Analysis: An Unidentified New Subtype?
  305. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa
  306. A Comparison of DSM-IV-TR and DSM-5 Diagnostic Criteria for Gambling Disorder in a Large Clinical Sample
  307. Analysis of the efficacy of an internet-based self-administered intervention (“Living Better”) to promote healthy habits in a population with obesity and hypertension: An exploratory randomized controlled trial
  308. Phenotypes in Gambling Disorder Using Sociodemographic and Clinical Clustering Analysis: An Unidentified New Subtype?
  309. Spanish validation of the pathological buying screener in patients with eating disorder and gambling disorder
  310. Anthropometrical phenotypes are important when explaining obstructive sleep apnea in female bariatric cohorts
  311. Gender-Related Patterns of Emotion Regulation among Patients with Eating Disorders
  312. Buying-shopping disorder—is there enough evidence to support its inclusion in ICD-11?
  313. The predictive capacity of DSM-5 symptom severity and impulsivity on response to cognitive-behavioral therapy for gambling disorder: A 2-year longitudinal study
  314. Suicidal ideation and history of suicide attempts in treatment-seeking patients with gambling disorder: The role of emotion dysregulation and high trait impulsivity
  315. Trait impulsivity and cognitive domains involving impulsivity and compulsivity as predictors of gambling disorder treatment response
  316. Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
  317. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial
  318. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study
  319. Food addiction and preoperative weight loss achievement in patients seeking bariatric surgery
  320. Food addiction: A transdiagnostic construct of increasing interest
  321. The Contribution of Sex, Personality Traits, Age of Onset and Disorder Duration to Behavioral Addictions
  322. Associations of food addiction and nonsuicidal self-injury among women with an eating disorder: A common strategy for regulating emotions?
  323. Effect of A Very Low-Calorie Ketogenic Diet on Food and Alcohol Cravings, Physical and Sexual Activity, Sleep Disturbances, and Quality of Life in Obese Patients
  324. Clustering of treatment-seeking women with gambling disorder
  325. Food addiction and impaired executive functions in women with obesity
  326. Neural Network Alterations Across Eating Disorders: A Narrative Review of fMRI Studies
  327. Visceral adiposity and insular networks: associations with food craving
  328. Other Specified Feeding or Eating Disorders (OSFED): Clinical heterogeneity and cognitive-behavioral therapy outcome
  329. A Randomized Trial of Virtual Reality-Based Cue Exposure Second-Level Therapy and Cognitive Behavior Second-Level Therapy for Bulimia Nervosa and Binge-Eating Disorder: Outcome at Six-Month Followup
  330. Impulsividad y conciencia del problema predicen la adherencia terapéutica y el abandono del tratamiento en el trastorno por juego de azar
  331. Corrigendum: Validation of the Spanish Version of the Yale Food Addiction Scale 2.0 (YFAS 2.0) and Clinical Correlates in a Sample of Eating Disorder, Gambling Disorder and Healthy Control Participants
  332. Underlying Mechanism of the Comorbid Presence of Buying Disorder with Gambling Disorder: A Pathways Analysis
  333. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
  334. Validation of the Caregiver Skills (CASK) scale in Catalonia: Concordance between caregivers in attitudes and behaviours
  335. Implementation of a Positive Technology Application in Patients With Eating Disorders: A Pilot Randomized Control Trial
  336. Validation of the Spanish Version of the Yale Food Addiction Scale 2.0 (YFAS 2.0) and Clinical Correlates in a Sample of Eating Disorder, Gambling Disorder, and Healthy Control Participants
  337. Sociodemographic and psychopathological predictors of criminal behavior in women with gambling disorder
  338. An overview of gambling disorder: from treatment approaches to risk factors
  339. Social Difficulties As Risk and Maintaining Factors in Anorexia Nervosa: A Mixed-Method Investigation
  340. Identifying tissues implicated in Anorexia Nervosa using Transcriptomic Imputation
  341. A real world study on the genetic, cognitive and psychopathological differences of obese patients clustered according to eating behaviours
  342. Gambling and Impulsivity Traits: A Recipe for Criminal Behavior?
  343. ERRATUM
  344. Are trans diagnostic models of eating disorders fit for purpose? A consideration of the evidence for food addiction
  345. How do online sports gambling disorder patients compare with land-based patients?
  346. Internet gaming disorder and online gambling disorder: Clinical and personality correlates
  347. Emotion Regulation as a Transdiagnostic Feature Among Eating Disorders: Cross-sectional and Longitudinal Approach
  348. A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson’s Disease
  349. Delay Discounting of Reward and Impulsivity in Eating Disorders: From Anorexia Nervosa to Binge Eating Disorder
  350. Cognitive Deficits in Executive Functions and Decision-Making Impairments Cluster Gambling Disorder Sub-types
  351. Weight Loss Trajectories in Bariatric Surgery Patients and Psychopathological Correlates
  352. Eating behavior style predicts craving and anxiety experienced in food-related virtual environments by patients with eating disorders and healthy controls
  353. Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa
  354. The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa
  355. Differences and Similarities Between Compulsive Buying and Other Addictive Behaviors
  356. A Randomised Controlled Comparison of Second-Level Treatment Approaches for Treatment-Resistant Adults with Bulimia Nervosa and Binge Eating Disorder: Assessing the Benefits of Virtual Reality Cue Exposure Therapy
  357. Validation of the Italian version of the Yale Food Addiction Scale 2.0 (I-YFAS 2.0) in a sample of undergraduate students
  358. Delay discounting and impulsivity traits in young and older gambling disorder patients
  359. Exploration of large, rare copy number variants associated with psychiatric and neurodevelopmental disorders in individuals with anorexia nervosa
  360. Testing virtual reality-based cue-exposure software: Which cue-elicited responses best discriminate between patients with eating disorders and healthy controls?
  361. Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa
  362. Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance
  363. Non-suicidal Self-Injury in Eating Disordered Patients: Associations with Heart Rate Variability and State-Trait Anxiety
  364. Brain Functional Connectivity Is Modified by a Hypocaloric Mediterranean Diet and Physical Activity in Obese Women
  365. A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling
  366. The Gut Metagenome Changes in Parallel to Waist Circumference, Brain Iron Deposition, and Cognitive Function
  367. Short-Term Treatment Outcomes and Dropout Risk in Men and Women with Eating Disorders
  368. Chances and Limitations of Video Games in the Fight against Childhood Obesity-A Systematic Review
  369. Food Addiction in Gambling Disorder: Frequency and Clinical Outcomes
  370. A comprehensive model of food addiction in patients with binge-eating symptomatology: The essential role of negative urgency
  371. Eating symptomatology and general psychopathology in patients with anorexia nervosa from China, UK and Spain: A cross-cultural study examining the role of social attitudes
  372. Correction: An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
  373. A Spanish Validation of the Canadian Adolescent Gambling Inventory (CAGI)
  374. Subjective craving and event-related brain response to olfactory and visual chocolate cues in binge-eating and healthy individuals
  375. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
  376. The role of affect-driven impulsivity in gambling cognitions: A convenience-sample study with a Spanish version of the Gambling-Related Cognitions Scale
  377. A systematic review and secondary data analysis of the interactions between the serotonin transporter 5-HTTLPR polymorphism and environmental and psychological factors in eating disorders
  378. Cognitive behavioral therapy for compulsive buying behavior: Predictors of treatment outcome
  379. Is gambling disorder associated with impulsivity traits measured by the UPPS-P and is this association moderated by sex and age?
  380. Excessive trading, a gambling disorder in its own right? A case study on a French disordered gamblers cohort
  381. Transgender and anxiety: A comparative study between transgender people and the general population
  382. Reward and punishment sensitivity in women with gambling disorder or compulsive buying: Implications in treatment outcome
  383. Genome-Wide Association Study Reveals First Locus for Anorexia Nervosa and Metabolic Correlations
  384. Dimensions of Compulsive Exercise across Eating Disorder Diagnostic Subtypes and the Validation of the Spanish Version of the Compulsive Exercise Test
  385. Self and other body perception in anorexia nervosa: The role of posterior DMN nodes
  386. The Involvement of a Concerned Significant Other in Gambling Disorder Treatment Outcome
  387. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions
  388. Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?
  389. Food Addiction in Bulimia Nervosa: Clinical Correlates and Association with Response to a Brief Psychoeducational Intervention
  390. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa
  391. Correlates of Non-suicidal Self-Injury and Suicide Attempts in Bulimic Spectrum Disorders
  392. Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity
  393. Exploring the Relationship between Reward and Punishment Sensitivity and Gambling Disorder in a Clinical Sample: A Path Modeling Analysis
  394. Retos en el desarrollo de intervenciones psicológicas y la práctica asistencial en salud mental
  395. Compulsive buying disorder clustering based on sex, age, onset and personality traits
  396. The neglect of eating disorders
  397. Compulsive Buying Behavior: Clinical Comparison with Other Behavioral Addictions
  398. Altered Decision-Making under Risk in Obesity
  399. Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits
  400. Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
  401. Facial expression to emotional stimuli in non-psychotic disorders: A systematic review and meta-analysis
  402. Compulsive Buying Behavior: Characteristics of Comorbidity with Gambling Disorder
  403. Sociodemographic Variables, Clinical Features, and the Role of Preassessment Cross-Sex Hormones in Older Trans People
  404. Treatment Outcome in Male Gambling Disorder Patients Associated with Alcohol Use
  405. The Influence of Personality Traits on Emotion Expression in Bulimic Spectrum Disorders: A Pilot Study
  406. Emotion Regulation and Excess Weight: Impaired Affective Processing Characterized by Dysfunctional Insula Activation and Connectivity
  407. Impact of alcohol consumption on clinical aspects of gambling disorder
  408. Retos de la investigación psicológica en salud mental
  409. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome
  410. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
  411. “Food Addiction” in Patients with Eating Disorders is Associated with Negative Urgency and Difficulties to Focus on Long-Term Goals
  412. Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance
  413. A new social-family model for eating disorders: A European multicentre project using a case–control design
  414. Gut Microbiota Interacts With Brain Microstructure and Function
  415. The Use of Videogames as Complementary Therapeutic Tool for Cognitive Behavioral Therapy in Bulimia Nervosa Patients
  416. 16p11.2 Locus modulates response to satiety before the onset of obesity
  417. Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment Outcome
  418. A Serious Videogame as an Additional Therapy Tool for Training Emotional Regulation and Impulsivity Control in Severe Gambling Disorder
  419. Physical activity in anorexia nervosa: How relevant is it to therapy response?
  420. Transcranial direct current stimulation (tDCS) in behavioral and food addiction: a systematic review of efficacy, technical, and methodological issues
  421. Olfaction in eating disorders and abnormal eating behavior: a systematic review
  422. Associations between eating disorder diagnoses, behaviors, and menstrual dysfunction in a clinical sample
  423. Psychological and Personality Predictors of Weight Loss and Comorbid Metabolic Changes After Bariatric Surgery
  424. Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
  425. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions
  426. Abnormal Social Reward Responses in Anorexia Nervosa: An fMRI Study
  427. Can an intervention based on a serious videogame prior to cognitive behavioral therapy be helpful in bulimia nervosa? A clinical case study
  428. Emotion regulation in disordered eating: Psychometric properties of the Difficulties in Emotion Regulation Scale among Spanish adults and its interrelations with personality and clinical severity
  429. Modulation of Higher-Order Olfaction Components on Executive Functions in Humans
  430. Non-suicidal Self-injury in Different Eating Disorder Types: Relevance of Personality Traits and Gender
  431. Unexpected online gambling disorder in late-life: a case report
  432. Systematic Review and Meta-Analysis of Prevalence Studies in Transsexualism
  433. The Relationship between Non-Suicidal Self-Injury and the UPPS-P Impulsivity Facets in Eating Disorders and Healthy Controls
  434. The Processing of Food Stimuli in Abnormal Eating: A Systematic Review of Electrophysiology
  435. Body Image Dissatisfaction and Eating-Related Psychopathology in Trans Individuals: A Matched Control Study
  436. Comparative analysis of distinct phenotypes in gambling disorder based on gambling preferences
  437. Identifying specific cues and contexts related to bingeing behavior for the development of effective virtual environments
  438. Mediational Role of Age of Onset in Gambling Disorder, a Path Modeling Analysis
  439. Hypothalamic Damage Is Associated With Inflammatory Markers and Worse Cognitive Performance in Obese Subjects
  440. Pathological gambling: understanding relapses and dropouts
  441. Non‐Suicidal Self‐Injury in Trans People: Associations with Psychological Symptoms, Victimization, Interpersonal Functioning, and Perceived Social Support
  442. Sex addiction and gambling disorder: similarities and differences
  443. Clinical, Psychopathological, and Personality Characteristics Associated with ADHD among Individuals Seeking Treatment for Gambling Disorder
  444. Predictors of Outcome among Pathological Gamblers Receiving Cognitive Behavioral Group Therapy
  445. Differences and Similarities Between Bulimia Nervosa, Compulsive Buying and Gambling Disorder
  446. Predictors for Good Therapeutic Outcome and Drop-out in Technology Assisted Guided Self-Help in the Treatment of Bulimia Nervosa and Bulimia like Phenotype
  447. A psychosocial risk factor model for female eating disorders: a European multicentre project
  448. Disruption of brain white matter microstructure in women with anorexia nervosa
  449. Is Non-suicidal Self-injury Related to Impulsivity in Anorexia Nervosa? Results from Self-report and Performance-based Tasks
  450. Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers
  451. Subtypes of Pathological Gambling with Concurrent Illegal Behaviors
  452. Food Addiction in a Spanish Sample of Eating Disorders: DSM-5 Diagnostic Subtype Differentiation and Validation Data
  453. Brain Iron Overload, Insulin Resistance, and Cognitive Performance in Obese Subjects: A Preliminary MRI Case-Control Study
  454. Physiological and Brain Activity After a Combined Cognitive Behavioral Treatment Plus Video Game Therapy for Emotional Regulation in Bulimia Nervosa: A Case Report
  455. Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament
  456. Explicit and Implicit Emotional Expression in Bulimia Nervosa in the Acute State and after Recovery
  457. Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
  458. Relationship between eating styles and temperament in an Anorexia Nervosa, Healthy Control, and Morbid Obesity female sample
  459. Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs
  460. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults
  461. Using ancestry-informative markers to identify fine structure across 15 populations of European origin
  462. A genome-wide association study of anorexia nervosa
  463. Anger in Pathological Gambling: Clinical, Psychopathological, and Personality Correlates
  464. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
  465. Video Game Addiction in Gambling Disorder: Clinical, Psychopathological, and Personality Correlates
  466. Contribution of Illegal Acts to Pathological Gambling Diagnosis: DSM-5 Implications
  467. Loss of Control over Eating: A Description of the Eating Disorder/Obesity Spectrum in Women
  468. Cognitive behaviour therapy response and dropout rate across purging and nonpurging bulimia nervosa and binge eating disorder: DSM-5 implications
  469. Typologies of young pathological gamblers based on sociodemographic and clinical characteristics
  470. Pathological gambling in eating disorders: Prevalence and clinical implications
  471. Creación de un consorcio europeo para el estudio de la deficiencia de GnRH (Acción COST BM1105)
  472. Video Game Therapy for Emotional Regulation and Impulsivity Control in a Series of Treated Cases with Bulimia Nervosa
  473. Clinical validation of a virtual environment for normalizing eating patterns in eating disorders
  474. Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration
  475. Late Onset Eating Disorders in Spain: Clinical Characteristics and Therapeutic Implications
  476. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
  477. ADHD symptomatology in eating disorders: a secondary psychopathological measure of severity?
  478. Decision-making deficits in pathological gambling: The role of executive functions, explicit knowledge and impulsivity in relation to decisions made under ambiguity and risk
  479. Gambling in Spain: update on experience, research and policy
  480. Is Pathological Gambling Moderated by Age?
  481. Maternal Anxiety, Overprotection and Anxious Personality as Risk Factors for Eating Disorder: A Sister Pair Study
  482. Co-occurrence of non-suicidal self-injury and impulsivity in extreme weight conditions
  483. Purging Behavior Modulates the Relationships of Hormonal and Behavioral Parameters in Women with Eating Disorders
  484. Differences in Cognitive Behavioral Therapy Dropout Rates between Bulimia Nervosa Subtypes Based on Drive for Thinness and Depression
  485. Eating-related Environmental Factors in Underweight Eating Disorders and Obesity: Are There Common Vulnerabilities During Childhood and Early Adolescence?
  486. The Facial and Subjective Emotional Reaction in Response to a Video Game Designed to Train Emotional Regulation (Playmancer)
  487. Personality subtypes in male patients with eating disorder: validation of a classification approach
  488. Eating Disorders and Pathological Gambling in Males: Can They Be Differentiated by Means of Weight History and Temperament and Character Traits?
  489. Affective speech interface in serious games for supporting therapy of mental disorders
  490. Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity
  491. Gambling on the stock market: an unexplored issue
  492. Correlates of Motivation to Change in Pathological Gamblers Completing Cognitive-Behavioral Group Therapy
  493. Video games as a complementary therapy tool in mental disorders: PlayMancer, a European multicentre study
  494. Low social interactions in eating disorder patients in childhood and adulthood: A multi-centre European case control study
  495. Aberrant brain microRNA target and miRISC gene expression in the anx/anx anorexia mouse model
  496. Comparison between Immigrant and Spanish Native-Born Pathological Gambling Patients
  497. Lifetime Obesity in Patients with Eating Disorders: Increasing Prevalence, Clinical and Personality Correlates
  498. Personality Changes in Bulimia Nervosa after a Cognitive Behaviour Therapy
  499. Perception of Autonomy and Connectedness Prior to the Onset of Anorexia Nervosa and Bulimia Nervosa
  500. Cognitive-Behavioral Therapy for Pathological Gambling in Parkinson’s Disease: A Pilot Controlled Study
  501. Fat Mass and Obesity-Associated Gene (<b><i>FTO</i></b>) in Eating Disorders: Evidence for Association of the rs9939609 Obesity Risk Allele with Bulimia nervosa and Anorexia nervosa
  502. Are online pathological gamblers different from non-online pathological gamblers on demographics, gambling problem severity, psychopathology and personality characteristics?
  503. Good Performance
  504. Male Eating Disorder Patients With and Without Non-suicidal Self-injury: A Comparison of Psychopathological and Personality Features
  505. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders
  506. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus
  507. Relevance of Social and Self-standards in Eating Disorders
  508. Poor Decision Making in Male Patients with Anorexia Nervosa
  509. Don't give up on GWAS
  510. Internalizing and Externalizing Behaviour Problems in Childhood Contribute to the Development of Anorexia and Bulimia Nervosa-A Study Comparing Sister Pairs
  511. Do Men with Eating Disorders Differ from Women in Clinics, Psychopathology and Personality?
  512. Redefining phenotypes in eating disorders based on personality: A latent profile analysis
  513. Suicide attempts in anorexia nervosa subtypes
  514. Does exposure and response prevention improve the results of group cognitive-behavioural therapy for male slot machine pathological gamblers?
  515. Effect of executive functioning, decision-making and self-reported impulsivity on the treatment outcome of pathologic gambling
  516. Motivation to change and pathological gambling: Analysis of the relationship with clinical and psychopathological variables
  517. High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders
  518. Editorial: Incoming editor-in-chief
  519. Gene–environment interaction in anorexia nervosa: relevance of non-shared environment and the serotonin transporter gene
  520. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa
  521. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients
  522. Role of the neurotrophin network in eating disorders’ subphenotypes: Body mass index and age at onset of the disease
  523. Specific eating disorder clusters based on social anxiety and novelty seeking
  524. Factors of risk and maintenance for eating disorders: psychometric exploration of the cross-cultural questionnaire (CCQ) across five European countries
  525. CYP2D6 polymorphism in patients with eating disorders
  526. Differentiating purging and nonpurging bulimia nervosa and binge eating disorder
  527. Evaluation of a guided internet self-treatment programme for bulimia nervosa in several European countries
  528. Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients
  529. Age of Onset in Pathological Gambling: Clinical, Therapeutic and Personality Correlates
  530. Functional variants of the serotonin receptor type 3A and B gene are associated with eating disorders
  531. Comorbilidad del juego patológico: variables clínicas, personalidad y respuesta al tratamiento
  532. Thin healthy women have a similar low bone mass to women with anorexia nervosa
  533. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment
  534. Male eating disorders and therapy: A controlled pilot study with one year follow-up
  535. Meta-analysis on drugs in people with eating disorders
  536. Predictors of early change in bulimia nervosa after a brief psychoeducational therapy
  537. Subtyping eating disordered patients along drive for thinness and depression
  538. Suicide attempts in bulimia nervosa: Personality and psychopathological correlates
  539. Executive functioning among female pathological gambling and bulimia nervosa patients: Preliminary findings
  540. Sex differences among treatment-seeking adult pathologic gamblers
  541. Internet-Based Cognitive-Behavioral Therapy for Bulimia Nervosa: A Controlled Study
  542. Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders: Comparison study of eating disorder subgroups
  543. Substance use disorders in women with anorexia nervosa
  544. Playmancer Project: A Serious Videogame as an Additional Therapy Tool for Eating and Impulse Control Disorders
  545. Anger expression in eating disorders: Clinical, psychopathological and personality correlates
  546. PlayMancer: A Serious Gaming 3D Environment
  547. Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: A European multicenter study
  548. Associations of individual and family eating patterns during childhood and early adolescence: a multicentre European study of associated eating disorder factors
  549. Reliability, Validity, and Classification Accuracy of a Spanish Translation of a Measure of DSM-IV Diagnostic Criteria for Pathological Gambling
  550. Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders
  551. Comparison study of full and subthreshold bulimia nervosa: Personality, clinical characteristics, and short-term response to therapy
  552. Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa
  553. Impulse control disorders in women with eating disorders
  554. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia
  555. Corrigenda
  556. Individual and family eating patterns during childhood and early adolescence: An analysis of associated eating disorder factors
  557. Comparison of personality risk factors in bulimia nervosa and pathological gambling
  558. Obsessive-compulsive and eating disorders: Comparison of clinical and personality features
  559. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case–control studies and evidence of publication bias
  560. Symptom Profile of Major Depressive Disorder in Women with Eating Disorders
  561. Blood Levels of Brain-Derived Neurotrophic Factor Correlate with Several Psychopathological Symptoms in Anorexia Nervosa Patients
  562. Childhood Eating and Weight in Eating Disorders: A Multi-Centre European Study of Affected Women and Their Unaffected Sisters
  563. Motivation to change in eating disorders: clinical and therapeutic implications
  564. Impulse control disorders in eating disorders: clinical and therapeutic implications
  565. Case–control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa
  566. Blindness and bulimia nervosa: A description of a case report and its treatment
  567. Evaluation and deployment of evidence based patient self-management support program for bulimia nervosa
  568. Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, Harm avoidance and minimum body mass index
  569. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations
  570. Self-injurious behaviour in people with eating disorders
  571. Which factors do provoke binge eating? An exploratory study in eating disorder patients
  572. Personality and psychopathological traits of males with an eating disorder
  573. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations
  574. Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa
  575. Marital status and eating disorders
  576. Characteristics of bulimic patients whose parents do or do not abuse alcohol
  577. The 5-HT2A −1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres
  578. Bulimia nervosa and misuse of orlistat: Two case reports
  579. Binge eating disorder onset by unusual parasitic intestinal disease: A case-report
  580. Transsexuialism and anorexia nervosa: A case report
  581. Body image in eating disorders and analysis of its relevance
  582. Outpatient group therapy for anorexia nervosa: A preliminary study
  583. Body size estimation and body dissatisfaction in eating disorder patients and normal controls